1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-62.13%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-65.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-108.93%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-106.87%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-107.11%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-107.05%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-108.75%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.49%
Slight or no buybacks while FSLR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-19.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-192.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-481.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
5.36%
10Y revenue/share CAGR under 50% of FSLR's 1881.02%. Michael Burry would suspect a lasting competitive disadvantage.
-8.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-24.46%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
83.11%
OCF/share CAGR of 83.11% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-532.42%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
29.72%
Positive 3Y OCF/share CAGR while FSLR is negative. John Neff might see a big short-term edge in operational efficiency.
96.49%
Positive 10Y CAGR while FSLR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-154.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
89.12%
3Y net income/share CAGR similar to FSLR's 87.99%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
-24.23%
Negative 5Y equity/share growth while FSLR is at 48.24%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
1.53%
Below 50% of FSLR's 34.62%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while FSLR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.26%
Firm’s AR is declining while FSLR shows 58.10%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
45.07%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.58%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.43%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-13.00%
We’re deleveraging while FSLR stands at 11.80%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.85%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.64%
We expand SG&A while FSLR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.